That analysis identified over 60 % of patients were at lifetime risk of CKD and 3 % progressed to ESKD, with predictors including older age, CV history, higher uACR, and renin–angiotensin–aldosterone system (RAAS) inhibitor use. This evidence concerns the gene REN and chronic kidney disease.